Latest News of TEVA
Teva Pharmaceutical (TEVA) Enters Into a License Agreement With Prestige Biopharma for the Commercialization of Tuznue in Europe
By Yahoo! Finance | 1 month ago
Bank of America Securities Raises PT on Teva Pharmaceutical Industries (TEVA), Keeps a Buy
By Yahoo! Finance | 1 month ago
BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid "Pivot to Growth" Strategy Execution
By Yahoo! Finance | 1 month ago